Prediction Model for Urinary Tract Infection
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to reduce unnecessary antibiotic use for urinary tract infections (UTIs), aiming to combat antibiotic resistance. The focus is on a prediction model (Decision Aid-prediction model) and a callback system to assess whether patients truly need antibiotics after an emergency room visit. Women treated in the ER for UTI symptoms and sent home with antibiotics may qualify for this study. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance UTI treatment and decrease antibiotic resistance.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What prior data suggests that this prediction model is safe for use in reducing unnecessary antibiotic use?
Research has shown that a decision aid with a prediction model can safely assist doctors in making better treatment choices for urinary tract infections (UTIs). This method employs machine learning, a type of artificial intelligence, to predict the presence of a UTI based on routine urine tests and other information, aiding doctors in determining the necessity of antibiotics.
Studies have found that these models enhance the accuracy of UTI diagnoses, reducing the likelihood of unnecessary antibiotic prescriptions. This is crucial, as overusing antibiotics can lead to resistance. Notably, using this decision aid does not involve new medications or risky procedures; it simply uses smart tools to guide treatment decisions.
No reports of harmful effects have emerged from using these prediction models. They are well-received because they provide additional information to healthcare providers, helping to avoid unnecessary antibiotic use, which benefits patient safety and public health.12345Why are researchers excited about this trial?
Researchers are excited about the Decision Aid-prediction model for urinary tract infections (UTIs) because it offers a new way to predict and manage the condition. Unlike traditional treatments that focus on antibiotics to fight infections, this model uses data and algorithms to help doctors accurately predict the likelihood of a UTI in patients who show up at the ER with symptoms. This approach could lead to more precise and personalized care, reducing unnecessary antibiotic use and improving patient outcomes. By providing doctors with a powerful decision-making tool, this model has the potential to enhance how UTIs are diagnosed and treated.
What evidence suggests that this prediction model is effective for reducing unnecessary antibiotic use in UTIs?
Research has shown that machine learning can predict urinary tract infections (UTIs) using lab and urine test results. One study found that a decision tree model correctly identified 87% of actual UTI cases, even with uneven data. Risk score models also help identify patients at high risk. AI tools have reduced incorrect antibiotic prescriptions, which is crucial for combating antibiotic resistance. This trial will evaluate a decision aid-prediction model for patients presenting to the ER with UTI symptoms. These findings suggest that prediction models could reduce unnecessary antibiotic use and improve treatment accuracy for UTIs.25678
Who Is on the Research Team?
David Sheyn, MD
Principal Investigator
University Hospitals Cleveland Medical Center
Are You a Good Fit for This Trial?
This trial is for individuals who visit the emergency department with symptoms of a urinary tract infection (UTI), such as burning during urination, frequent urge to pee, or cloudy urine. The study excludes specific details on eligibility criteria.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive antibiotics based on a prediction model and are monitored for UTI symptoms
Follow-up
Participants are monitored for safety and effectiveness after treatment, with a focus on antibiotic resistance
What Are the Treatments Tested in This Trial?
Interventions
- Decision Aid-prediction model
Find a Clinic Near You
Who Is Running the Clinical Trial?
Case Western Reserve University
Lead Sponsor